Market Overview

Otonomy Appoints Eric Loumeau as General Counsel and COO

Share:

Otonomy, Inc. (Nasdaq: OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle ear, today announced the appointment of Eric Loumeau as general counsel and chief compliance officer. Mr. Loumeau has over 23 years of experience as in-house legal counsel and compliance officer for several biopharmaceutical companies and as outside corporate counsel supporting healthcare and technology-based client companies.

"Eric is a welcome addition to the Otonomy team given his legal and senior management experience across a broad range of areas including public company securities filings, financings, collaboration agreements, corporate governance, and attention to general corporate legal matters," said David A. Weber, Ph.D., president and CEO of Otonomy. "I expect that Eric will also make a significant contribution this year in overseeing our corporate compliance efforts as we prepare for the commercial launch of AuriProTM in the first quarter of 2016."

Prior to joining Otonomy, Mr. Loumeau was the vice president of legal affairs at The Medicines Company, which he joined following the company's acquisition of Rempex Pharmaceuticals. At Rempex, Mr. Loumeau served as vice president, chief financial officer and chief compliance officer and in this capacity he was involved in the completion of several asset acquisitions and financings as well as having primary responsibility for corporate compliance. Previously, Mr. Loumeau also served as general counsel and chief compliance officer for Hollis-Eden Pharmaceuticals, a publicly-traded biotechnology company. Mr. Loumeau's experience as outside corporate counsel at national law firms includes roles as a partner at Bass, Berry & Sims, PLC, and Mintz Levin Cohn Ferris Glovsky and Popeo PC, partner and associate at Cooley LLP, and an associate at Skadden, Arps, Slate, Meagher & Flom LLP.

Mr. Loumeau obtained a juris doctorate from Boalt Hall School of Law at the University of California, Berkeley, including spending his final year at Harvard Law School through the Harvard-Boalt Exchange Program. He obtained a bachelor's degree in finance from Brigham Young University.

Posted-In: News Press Releases

 

Related Articles (OTIC)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Why Citi's $722 PT On Netflix Is Not A 'Ridiculous' Number Anymore

Matrix Asset Advisors: 'You Are Getting Paid Nicely While You Wait For A Turnaround At McDonald's'